A detailed history of Phoenix Holdings Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 1,767 shares of REGN stock, worth $1.26 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,767
Previous 950 86.0%
Holding current value
$1.26 Million
Previous $998,000 86.07%
% of portfolio
0.03%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$1024.09 - $1201.76 $836,681 - $981,837
817 Added 86.0%
1,767 $1.86 Million
Q2 2024

Aug 12, 2024

SELL
$883.2 - $1071.19 $338,265 - $410,265
-383 Reduced 28.73%
950 $998,000
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $411,626 - $452,967
456 Added 52.0%
1,333 $1.28 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $185,268 - $210,726
239 Added 37.46%
877 $770,000
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $511,720 - $623,989
-739 Reduced 53.67%
638 $525,000
Q2 2023

Aug 07, 2023

BUY
$700.03 - $830.35 $499,821 - $592,869
714 Added 107.69%
1,377 $989,000
Q1 2023

May 11, 2023

BUY
$680.49 - $826.97 $451,164 - $548,281
663 New
663 $544,000
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $57,397 - $72,432
-100 Reduced 18.28%
447 $313,000
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $783,592 - $1.06 Million
-1,429 Reduced 72.32%
547 $325,000
Q1 2022

May 10, 2022

SELL
$595.12 - $698.43 $200,555 - $235,370
-337 Reduced 14.57%
1,976 $1.38 Million
Q4 2021

Feb 07, 2022

SELL
$543.48 - $670.97 $126,087 - $155,665
-232 Reduced 9.12%
2,313 $1.49 Million
Q3 2021

Oct 27, 2021

BUY
$574.03 - $680.96 $1.46 Million - $1.73 Million
2,545 New
2,545 $1.54 Million
Q2 2021

Aug 10, 2021

SELL
$472.8 - $558.54 $1.18 Million - $1.39 Million
-2,494 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$446.73 - $548.2 $860,848 - $1.06 Million
1,927 Added 339.86%
2,494 $1.18 Million
Q4 2020

Feb 11, 2021

BUY
$478.3 - $607.98 $271,196 - $344,724
567 New
567 $270,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.